ObvioHealth Appoints Two New Company Executives
New hires expected to reinforce the company's clinical and digital trial expertise.
ObvioHealth, a virtual research organization (VRO), has announced the appointmet of John Cassidy as chief financial officer and Florence Mowlem as VP of science. Previously, Cassidy served as the global head of product and commercial for eClinical at LabCorp while Mowlem joins ObvioHealth after working for Medable, where she led a team driving the implementation of electronic clinical outcomes assessments (eCOAs).
"ObvioHealth has a unique model blending clinical expertise with a robust platform to deliver stronger evidence and accelerated timelines for drug development," said Cassidy, in a company press release. "It is the perfect time to join this experienced team to help bring the business to a new level of growth."
Reference: ObvioHealth Strengthens Leadership Team with Key Industry Appointments. PR Newswire. October 17, 2023. Accessed October 19, 2023. https://www.prnewswire.com/news-releases/obviohealth-strengthens-leadership-team-with-key-industry-appointments-301956006.html
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
